One way we can try to measure the level of fear in ... In trading on Tuesday, shares of Krystal Biotech Inc (Symbol: KRYS) entered into oversold territory, hitting an RSI reading of 26.1, after ...

Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...

Investors considering a purchase of Krystal Biotech Inc (Symbol: KRYS) stock ... and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge ...

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

Professor Emeritus Herb Boyer's discovery of recombinant DNA changed medicine, ushering in a new era in biological treatments ...

I often refer to Regeneron as a “Biotech Juggernaut” because it seems ... which has blockbuster potential if they can show it is operative in former smokers. Another one of Regeneron’s ...

we recognize the challenging market environment facing the biotechnology sector as a whole. In times like these, we believe the most important thing we can do for our shareholders is to remain ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

The data demonstrate that inhibiting PLA2G15 can significantly improve the disease course in a well-established model for Niemann-Pick type C (NPC), a lysosomal storage disorder also referred to as ...

During this challenging time, there are several topics that boards and management teams of biotech companies can consider in order to be well positioned to maximize value when opportunity ...

Zurich-based start-up Veraxa Biotech has reached a deal to merge with ... "Our platform technologies can be applied to empower multiple therapeutic strategies spanning next-generation antibody ...